Washington, D.C.-based Children’s National Hospital administered Zynteglo, a $2.8 million gene therapy, to its first pediatric patient with the help of Clearway Health.
The bone disease drug Prolia has a new boxed warning, the FDA’s most prominent warning, because of an increased risk of severe hypocalcemia among chronic kidney disease patients.
AI will revolutionize every aspect of healthcare, including drug, medical device, and medical software regulation; clinical education and more, according to three panelists at a Jan. 12 forum hosted by Philadelphia-based University of Pennsylvania’s Le…
Charlottesville-based University of Virginia Health is creating a telehealth clinic that will focus on medically underserved communities all over the world.
Buffalo, N.Y.-based Independent Health’s president and CEO Michael Cropp, MD, will be passing his president title on to Jim Dunlop, the independent, nonprofit health system’s current executive vice president and CFO.
Philadelphia-based University of Pennsylvania researchers completed the first successful experiment of circulating a deceased donor’s blood through a genetically engineered pig liver.
Connecticut’s office of health strategy has rejected Johnson Memorial Hospital’s proposal to close its labor and delivery unit, arguing that it would adversely affect the less wealthy, reduce access to care and not save patients money, CT Insider repor…
This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.